Ep. 90: Challenges in Diagnosis and Treatment of Chronic Urticaria in Skin of Color
How do hives look in skin of color, and why are diagnoses often delayed? In this episode, we explore unique barriers, lack of visual aids, and the need for culturally sensitive care to improve outcomes.
Ep. 89 - Health Insurance 101 for Doctors: Navigating Claims and Coverage
Are you a healthcare provider frustrated by the health insurance approval process? This episode unpacks how healthcare providers can navigate health insurance, from documentation and prior authorizations to overcoming medication denials.
Ep. 88 - How to Get Your Meds Approved: Appealing Insurance Denial
This episode explores health insurance, covering how to collaborate with your doctor on paperwork, what a prior authorization is and what steps to take if a medication is denied.
Ep. 87 - What biologic therapies are available for allergic conditions?
We discuss the science behind 8 biologics available for allergic diseases , how they work and the long process for approval for various diseases.
Ep. 85: Navigating Biologic Therapy – What You Need to Know
We unpack how to start biologic therapy with confidence: covering insurance, specialty pharmacies, and tips for a smooth treatment journey.
Ep. 84: Biologic Medication Facts vs. Myths
Discover the truth behind common biologic medication myths with Dr. Rutland. Learn how biologics work and why they’re changing treatment for asthma and eczema.
Ep. 83: What is a biologic medication?
Biologic medications are an exciting advancement in medicine. Learn how biologic therapy works and how these treatments improve quality of life for patients with asthma and other allergic diseases.
Ep. 82: The Future of Chronic Spontaneous Urticaria Treatments
Explore the future of Chronic Spontaneous Urticaria (CSU) treatment. In this episode, we delve into groundbreaking advancements, including emerging biologics and therapies that promise to transform the landscape of CSU care: Dupilumab, Remibrutinib, and Barzolvolimab. We also discuss Omalizumab, a current treatment option, and the evolving understanding of CSU's root cause.